Company: TDBCP
Filing Date: 2025-10-09
Form Type: 424B3
Source: 0001140361-25-037791
Chunk: 42

Company: TORONTO DOMINION BANK
Filing Date: 2025-10-09
Form: 424B3
Chunk 42
---
, tax, and other advisors. BofAS and its affiliates may use this product supplement and the accompanying prospectus, together with the applicable term sheet, in market-making transactions for any LIRNs after their initial sale solely for the purpose of providing investors with the description of the terms of LIRNs that were made available to investors in connection with the initial distribution of LIRNs. Secondary market investors should not, and will not be authorized to rely on these documents for information regarding TD or for any purpose other than that described in the immediately preceding sentence. Conflict of Interest TDS is an affiliate of TD and, as such, has a “conflict of interest” in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (“ FINRA”) Rule 5121. Additionally, TD will receive the net proceeds from the initial public offering of LIRNs, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, this offering of LIRNs will be conducted in compliance with the provisions of FINRA Rule 5121 and TDS is not permitted to sell LIRNs to an account over which it exercises discretionary authority without the prior specific written approval of the account holder. Selling Restrictions European Economic Area and United Kingdom None of the applicable pricing supplement, this product supplement or the accompanying prospectus is a prospectus for the purposes of the Prospectus Regulation (as defined below). The applicable pricing supplement, this product supplement and the accompanying prospectus have been prepared on the basis that any offer of LIRNs in the European Economic Area (the “ EEA”) or in the United Kingdom will only be made to a legal entity which is a qualified investor under the Prospectus Regulation (“ Qualified Investors”). Accordingly any person making or intending to make an offer in the EEA or in the United Kingdom of LIRNs which are the subject of the offering contemplated in the applicable pricing supplement, this product supplement and the accompanying prospectus may only do so with respect to Qualified Investors. Neither TD nor the agents have authorized, nor do they authorize, the making of any offer of notes other than to Qualified Investors. The expression “ Prospectus Regulation” means Regulation (EU) 2017/1129, as may be amended. PS-35 Prohibition on Sales to EEA Retail Investors LIRNs are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these purposes, a retail investor